Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-027746
Filing Date
2024-11-26
Accepted
2024-11-26 17:00:06
Documents
1
Period of Report
2024-11-25

Document Format Files

Seq Description Document Type Size
1 form4-11262024_051101.html 4  
1 form4-11262024_051101.xml 4 3450
  Complete submission text file 0001415889-24-027746.txt   4944
Mailing Address 221 W PHILADELPHIA ST SUITE 60W YORK PA 17401-2991
Business Address
CHOLMONDELEY PAULA H (Reporting) CIK: 0001193675 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41855 | Film No.: 241505083

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Issuer) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)